Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 8,604 shares at $96.47 ($830K) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Scheduled sale ($830k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.47 | 4,302 | $415K | 50.0% |
| 2 | $96.47 | 4,302 | $415K | 50.0% |
| Total | $96.47 avg | 8,604 | $830K | 100% |
| Filing → |
| PVLA | SELL | 2026-07-17 | $642K | — | Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |